Archives

by in
Entry Author Date Location
WaVe Gets $18M to Solve RNA’s “Underappreciated” Chemistry Problem 02/02/15 Boston
Alnylam CEO: More Cash in Hand Is to Fuel Expansion From Within 01/21/15 Boston
Dallas’ AveXis Gets $10M to Bring Gene Therapy to Rare Spinal Disorder 01/20/15 Texas
West Coast Biotech Roundup: Hep C, 23andMe, Kite, Cash, Isis & More 01/08/15 San Francisco
West Coast Biotech Roundup: Amgen, Ariosa, Avanir, Audentes & More 12/04/14 San Diego
After Unlikely Idenix Sale, Renaud Jumps to RaNA to Outfox Junk DNA 12/01/14 Boston
John Maraganore: From “Prototypical Geek” To Canny Alnylam Chief 09/07/14 Boston
BIO 2014: Why San Diego is a Hub for RNA R&D and Drug Development 06/23/14 San Diego
OncoGenex Retrenches, and Searches for Answers, After Failed Trial 05/22/14 Seattle
West Coast Biotech Roundup: Lumena/Shire, Isis, Janssen Labs & More 05/16/14 San Diego
Biogen, Eisai Join Up in Alzheimer’s Drug Pact 03/05/14 Boston
Isis Shares Climb on Early Data for Rare Spine Disorder Drug 02/21/14 Boston
San Diego Life Sciences Roundup: Isis, Receptos, Suneva, and More 01/17/14 San Diego
The Top Stories of 2013 at Xconomy San Francisco and Xperience 12/30/13 San Francisco
Building Biotechs to Last: See the Agenda for Monday 12/05/13 San Francisco
Glaxo Setting Up San Diego Outpost to Oversee its Westward Expansion 11/25/13 San Diego
Armo BioSciences Joins the Cancer Immunotherapy Party With $20M 11/25/13 San Francisco
Building Biotechs to Last: A Sneak Peek at the Agenda for Dec. 9 11/19/13 San Francisco
Catabasis Scores $32M Series B Round With IPO in Sight 11/15/13 Boston
Building Biotechs to Last: See Bonnie Anderson, Dan Bradbury & More 11/07/13 Boston
Lessons from the St. Louis Cardinals and ‘Building Biotechs to Last’ 10/30/13 San Francisco
San Diego’s Arcturus Raises $5M for “Best-in-Class” RNAi Technology 10/22/13 San Diego
Join Xconomy for Profiles in Biotech Perseverance in SF Dec. 9 10/03/13 National
East Coast Life Sciences Roundup: Genocea, Biogen, OvaScience, & More 09/13/13 Boston
San Diego Life Sciences Roundup: Isis, Neurocrine, MEI, and More 09/12/13 San Diego
Amicus, Biogen Team Up on Parkinson’s Drug Deal 09/10/13 Boston
Biogen Idec Strikes $100M Upfront Deal With Isis for Neurology 09/09/13 Boston
San Diego Life Sciences Roundup: Evoke Pharma, Isis, Otonomy, & More 09/06/13 San Diego
Sage Taps Former Shire Exec to Lead CNS Drugs Into Clinical Trials 08/14/13 Boston
San Diego Life Sciences Roundup: Sophiris, Isis, Qualcomm, & More 08/08/13 San Diego
Page 1 of 5 next page »